Atlantis Symbicort

A Two Stage Randomized, Open-Label, Parallel Group, Phase III, Multicenter, 7 Month Study to Assess the Efficacy & Safety of SYMBICORT pMDI Adminstered Either as Fixed or as an Adjustable Regimen Versus a Fixed Regimen of Advair in Subjects 12 Yrs of Age and Older With Asthma.

The purpose of this study is to determine whether Symbicort compared with Advair, will be more effective in controlling asthma in adults and adolescents.

Inclusion Criteria:

• Diagnosis of asthma
• Baseline lung function tests as determined by protocol
• Required and received treatment with inhaled corticosteroids within timeframe and doses specified in protocol

Exclusion Criteria:

• Has required treatment with any non-inhaled corticosteroid within previous 30 days, sensitivity to drugs specified in the protocol, or requires treatment with a beta-blockers
• Had cancer within previous 5 years or currently has any other significant disease or disorder as judged by the investigator